Finanzwire Finanzwire
Basculer en Français
10319 Companies
213914 Keywords
143597 Articles
113226 Press releases
Headlines Articles Press releases Guangzhou Wanglaoji Pharmaceutical Company Remove
  1. Home
  2. Companies
  3. Guangzhou Wanglaoji Pharmaceutical Company
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/07/2024 at 18:05, 1 year 11 months ago

    Launch of WALOVI's international identity by Wanglaoji in Paris during the Sino-French Gastronomic Festival

    International Market Wanglaoji WALOVI Sino-French Gastronomic Festival Chinese Herbal Tea
  • BRIEF

    published on 05/07/2024 at 10:05, 1 year 11 months ago

    Wanglaoji Launches WALOVI Brand at Sino-French Food Carnival in Paris

    Cultural Exchange Wanglaoji WALOVI Herbal Tea Sino-French Relations
  • PRESS RELEASE

    published on 05/07/2024 at 10:00, 1 year 11 months ago

    Enjoy the taste of spring together and convey good wishes—— Wanglaoji showed up at the 'Sino-French Food Carnival' and Launched the International Brand Identity WALOVI in Paris

    Sino-French Food Carnival celebrates 60th anniversary of China-France relations on Seine River. Wanglaoji introduces herbal tea brand WALOVI to overseas markets with focus on healthy consumption trend
    Wanglaoji Herbal Tea Sino-French Food Carnival Overseas Market Healthy Consumption
    Logo of Guangzhou Wanglaoji Pharmaceutical Company
Accesswire
  • Published on 04/29/2026 at 15:30, 2 hours 47 minutes ago

    Infield Minerals Announces Financing

  • Published on 04/29/2026 at 15:15, 3 hours 2 minutes ago

    Reeflex Solutions Inc. Announces Filing of Q2 2026 Financial Results

  • Published on 04/29/2026 at 15:10, 3 hours 7 minutes ago

    Karbon-X Introduces Corporate Emissions Calculator as Pressure to Quantify Carbon Exposure Accelerates

  • Published on 04/29/2026 at 14:31, 3 hours 46 minutes ago

    Worksport (NASDAQ:WKSP) Secures Tri-State Distribution, Books Initial Orders, Projected to be 7-Figure + Annual Account

  • Published on 04/29/2026 at 14:30, 3 hours 47 minutes ago

    Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs

View all ACCESSWIRE
EQS Group
  • Published on 04/29/2026 at 18:05, 12 minutes ago

    VerifyVASP acquires Sygna, consolidating the global Travel Rule network

  • Published on 04/29/2026 at 18:00, 17 minutes ago

    Partners Group invests in fleet expansion of portfolio company North Star, a leading offshore infrastructure services provider

  • Published on 04/29/2026 at 18:00, 17 minutes ago

    Trexel and Roctool announce global lightweighting alliance

  • Published on 04/29/2026 at 17:40, 37 minutes ago

    AlborHill Marks Its Entry into Germany with a Comprehensive Trading Infrastructure

  • Published on 04/29/2026 at 17:30, 47 minutes ago

    Porsche AG resolutely pushes ahead with strategic realignment

View all EQS
Les Echos
  • Published on 04/29/2026 at 18:10, 7 minutes ago

    Amemdment of the resolution n8 submitted to the AGM of 30 April 2026

  • Published on 04/29/2026 at 18:00, 17 minutes ago

    Availability of the 2025 Universal Registration Document

  • Published on 04/29/2026 at 17:45, 32 minutes ago

    Availability of Deezer’s 2025 Universal Registration Document including the Annual Financial Report

  • Published on 04/29/2026 at 17:45, 32 minutes ago

    Availability of preliminary documents for the 2026 Annual General Meeting

  • Published on 04/29/2026 at 17:45, 32 minutes ago

    CRIT : First quarter 2026 revenue : 785.6 €m (+2,5%)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy